News Medical on MSN

GLP-1 drugs calm inflammation beyond diabetes and weight loss

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...
News-Medical.Net on MSN

Do GLP-1 drugs cause cancer? New review says no, may even protect

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...
Healio

Oral quadruple receptor agonist confers weight loss with minimal GI adverse events

A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
Medscape

GI Safety Similar for Popular Weight-Loss Drugs

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...
Health and Me on MSN

Taking Ozempic, Wegovy, or Mounjaro? Experts Warn Of Rare But Severe Reaction

Health officials have issued a warning for Ozempic, Wegovy, Rybelsus, and Mounjaro users after reports of severe reactions linked to GLP-1 drugs. Here’s what the alert means and how to stay safe. Keep ...